Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Market Cap ($372.78 Million)
Market Cap & Net Worth: Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (GU5)
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited market cap. Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (F:GU5) has a market capitalization of $372.78 Million (€318.86 Million) as of November 4, 2026. Listed on the F stock exchange, this Germany-based company holds position #13474 globally and #1409 in its home market, demonstrating a 1.40% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited's stock price €1.45 by its total outstanding shares 219900000 (219.90 Million). Also see Guangzhou Baiyunshan Pharmaceutical Hold cash flow conversion for how efficiently the company converts equity into cash flow.
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Market Cap History (2015–2026)
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited market cap history from 2015 to 2026. Data shows growth from $50.54 Million to $372.78 Million (19.98% CAGR). Check GU5 stock price and chart for real-time trading data and today's change.
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore GU5 net assets growth trend to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.01x
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited's market cap is 0.01 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.17x
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited's market cap is 0.17 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $57.10 Million | $20.04 Billion | $1.51 Billion | 0.00x | 0.04x |
| 2017 | $66.59 Million | $20.95 Billion | $2.06 Billion | 0.00x | 0.03x |
| 2018 | $96.79 Million | $42.23 Billion | $3.44 Billion | 0.00x | 0.03x |
| 2019 | $102.29 Million | $64.95 Billion | $3.19 Billion | 0.00x | 0.03x |
| 2020 | $91.99 Million | $61.67 Billion | $2.92 Billion | 0.00x | 0.03x |
| 2021 | $157.88 Million | $69.01 Billion | $3.72 Billion | 0.00x | 0.04x |
| 2022 | $262.49 Million | $70.79 Billion | $3.97 Billion | 0.00x | 0.07x |
| 2023 | $334.26 Million | $75.52 Billion | $4.06 Billion | 0.00x | 0.08x |
| 2024 | $550.16 Million | $74.99 Billion | $2.84 Billion | 0.01x | 0.19x |
| 2025 | $501.32 Million | $77.66 Billion | $2.98 Billion | 0.01x | 0.17x |
Competitor Companies of GU5 by Market Capitalization
Companies near Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited in the global market cap rankings as of November 4, 2026. Also see Guangzhou Baiyunshan Pharmaceutical Hold assets under control for a full breakdown of the balance sheet.
Key companies related to Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited by market ranking:
- McKesson Corporation (NYSE:MCK): Ranked #247 globally with a market cap of $101.38 Billion USD.
- Cencora Inc. (NYSE:COR): Ranked #450 globally with a market cap of $61.32 Billion USD.
- Cardinal Health Inc (NYSE:CAH): Ranked #625 globally with a market cap of $43.01 Billion USD.
- Sigma Healthcare Ltd (AU:SIG): Ranked #1151 globally with a market cap of $22.38 Billion USD ( AU$31.63 Billion AUD).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #247 | McKesson Corporation | NYSE:MCK | $101.38 Billion | $998.38 |
| #450 | Cencora Inc. | NYSE:COR | $61.32 Billion | $337.84 |
| #625 | Cardinal Health Inc | NYSE:CAH | $43.01 Billion | $254.33 |
| #1151 | Sigma Healthcare Ltd | AU:SIG | $22.38 Billion | AU$2.74 |
Market Capitalization of Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (2015–2026)
Market capitalization of Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited from 2015 to today. Between 2015 and today, Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited's market cap moved from $50.54 Million to $ 372.78 Million, with a yearly change of 19.98%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €372.78 Million | -25.64% |
| 2025 | €501.32 Million | -8.88% |
| 2024 | €550.16 Million | +64.59% |
| 2023 | €334.26 Million | +27.35% |
| 2022 | €262.49 Million | +66.26% |
| 2021 | €157.88 Million | +71.63% |
| 2020 | €91.99 Million | -10.08% |
| 2019 | €102.29 Million | +5.68% |
| 2018 | €96.79 Million | +45.37% |
| 2017 | €66.59 Million | +16.61% |
| 2016 | €57.10 Million | +12.97% |
| 2015 | €50.54 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 3rd, 2026 the market cap of Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $372.78 Million USD |
| MoneyControl | $372.78 Million USD |
| MarketWatch | $372.78 Million USD |
| marketcap.company | $372.78 Million USD |
| Reuters | $372.78 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited engages in the pharmaceutical and healthcare industry in the People's Republic of China and internationally. The company operates through Modern Chinese Medicine Business, Chemical Pharmaceutical Technology Business, Natural Beverage Business, Pharmaceutical Commercial Business, and Other segments. It is involved in the research, develo… Read more